Amwell reports Q2 2026 revenue of $52M, narrows net loss, and expects positive cash flow by Q4

Amwell announced its financial results for Q2 2026, reporting total revenue of $52 million, hitting the top end of its guidance. Subscription revenue reached $25.7 million, and the company recorded a net loss of $9.6 million, an improvement from the previous quarter. Adjusted EBITDA loss narrowed to $1.2 million, reflecting operational progress. Amwell raised its 2026 revenue outlook to $200-$205 million and expects positive cash flow from operations by Q4 2026, signaling improved financial health and growth potential.